FEMOCARE
February 2, 2026
FENOCOLD
February 2, 2026
FEMOCARE
₹190.00
Composition:
Hydroxyprogesterone Caproate I.P. 500 mg
Packaging:
2 ml
Description
FEMOCARE Injection is a prescription hormonal preparation containing Hydroxyprogesterone Caproate, a long-acting progestin. It is used in obstetrics to support pregnancy in women with a history of preterm birth.
Indication
Indication
-
Primary Use: To lower the risk of preterm birth in women who have a history of at least one spontaneous preterm birth.
-
It is administered as a weekly intramuscular injection, typically starting at 16-20 weeks of pregnancy and continuing until week 37.
-
Side Effects
Side Effects
-
Pain, swelling, itching, or bruising at the injection site.
-
Fluid retention, swelling.
-
Nausea, diarrhea.
-
Drowsiness.
Reviews 0
Related products
-
FEROZOF
₹300.00 -
CEFMOL-TZ
₹188.64 -
CEFMOL-250
₹30.69
Reviews
There are no reviews yet.